- Liquid SLU-PP-332 is a cGMP liquid research solution containing 7.5MG per ML in a 30ML format , designed for laboratory investigations involving ERR pathway activity, exercise-mimetic signaling, mitochondrial metabolism, skeletal muscle adaptation, oxidative energy pathways, endurance-associated models, and metabolic flexibility research
Oral and injectable forms may cause mild digestive discomfort or injection site reactions, and unknown systemic effects or interactions with medications cannot be ruled out
This is the metabolic-rate component community framing is that glucagon agonism is why retatrutide produces weight loss numbers no GLP-1/GIP-only compound has matched
Supports Fat Metabolism Helps break down and eliminate fat, aiding in weight loss and improved body composition
Systemic reviews in 2025 still classify BPC157 as investigational, stressing that chronicuse safety in humans is unknown